<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Gouveia N</submitter><funding>European Commission</funding><pagination>100915</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12494807</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>6(1)</volume><pubmed_abstract>&lt;h4>Purpose&lt;/h4>To characterize the genetic, structural, and patient-reported visual function features in a multicenter cohort of patients with retinitis pigmentosa GTPase regulator (&lt;i>RPGR&lt;/i>)-associated retinal degeneration.&lt;h4>Design&lt;/h4>A cross-sectional, exploratory, international, multicenter study conducted across 3 academic centers.&lt;h4>Subjects&lt;/h4>The study included 102 eyes from 51 patients (37.3% female) with genetically confirmed &lt;i>RPGR&lt;/i>-associated retinal degeneration. Only male and female patients with a retinitis pigmentosa (RP) phenotype were included, as well as female carriers from RP pedigrees with retinal degeneration.&lt;h4>Methods&lt;/h4>Genetic variants were identified and visual acuity (VA) was recorded. Retinal phenotype was classified using fundus autofluorescence</pubmed_abstract><journal>Ophthalmology science</journal><pubmed_title>Retinitis Pigmentosa GTPase regulator-Associated Retinal Degeneration: Integrating Patient-Reported Outcomes, Genetic, and Structural Biomarkers.</pubmed_title><pmcid>PMC12494807</pmcid><funding_grant_id>739543</funding_grant_id><pubmed_authors>Gouveia N</pubmed_authors><pubmed_authors>Karuntu J</pubmed_authors><pubmed_authors>Marques JP</pubmed_authors><pubmed_authors>Silva R</pubmed_authors><pubmed_authors>Almushattat H</pubmed_authors><pubmed_authors>Boon C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Retinitis Pigmentosa GTPase regulator-Associated Retinal Degeneration: Integrating Patient-Reported Outcomes, Genetic, and Structural Biomarkers.</name><description>&lt;h4>Purpose&lt;/h4>To characterize the genetic, structural, and patient-reported visual function features in a multicenter cohort of patients with retinitis pigmentosa GTPase regulator (&lt;i>RPGR&lt;/i>)-associated retinal degeneration.&lt;h4>Design&lt;/h4>A cross-sectional, exploratory, international, multicenter study conducted across 3 academic centers.&lt;h4>Subjects&lt;/h4>The study included 102 eyes from 51 patients (37.3% female) with genetically confirmed &lt;i>RPGR&lt;/i>-associated retinal degeneration. Only male and female patients with a retinitis pigmentosa (RP) phenotype were included, as well as female carriers from RP pedigrees with retinal degeneration.&lt;h4>Methods&lt;/h4>Genetic variants were identified and visual acuity (VA) was recorded. Retinal phenotype was classified using fundus autofluorescence</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Jan</publication><modification>2026-06-15T06:09:34.903Z</modification><creation>2026-06-15T03:08:41.867Z</creation></dates><accession>S-EPMC12494807</accession><cross_references><pubmed>41049110</pubmed><doi>10.1016/j.xops.2025.100915</doi></cross_references></HashMap>